LakeShore Biopharma Co., Ltd LSB
0.63 USD 0.00 (+0.00%)
At closeSep 19, 2025, 4:00 PM EDT
0.627 Day range 0.7899
1.88 52-week range 11.20
- YTD
- 0.00%
- 1 year
- 0.00%
News
businesswire.com LSB Industries, Inc. Reports Operating Results for the 2026 Third Quarter OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the third quarter ended September 30, 2026. Third Quarter…
businesswire.com LSB Industries, Inc. Schedules 2026 Third Quarter Results Release for Wednesday, October 28th and Conference Call for Thursday, October 29th OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the third quarter ended September 30, 2026 on October 28, 2026…
businesswire.com LSB Industries, Inc. to Participate in Upcoming Investor Conferences OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”), (NYSE: LXU), today announced that its Chief Financial Officer, Cheryl Maguire and its Chief Commercial Officer, Damien Renwick will be…
seekingalpha.com LSB Industries: Why Cost Advantage Makes It A Buy LSB Industries is rated Buy with a $13.50 target, leveraging a structural U.S. natural gas cost advantage over European peers. Operational efficiency gains, particularly at the El Dorado plant, and a…
businesswire.com LSB Industries, Inc. Reports Operating Results for the 2026 Second Quarter OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the second quarter ended June 30, 2026. Second Quarter 2026…
businesswire.com LSB Industries, Inc. Schedules 2026 Second Quarter Results Release for Wednesday, July 29th and Conference Call for Thursday, July 30th OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the second quarter ended June 30, 2026 on July 29, 2026 after…
seekingalpha.com LSB Industries: Ongoing Margin Execution Is Not Being Appreciated Enough LSB Industries, a top-5 U.S. ammonia producer, and a nitrogen-oriented chemical specialist has outperforming other material peers and the Russell 2000 meaningfully this year. Despite facing 900bps of…
businesswire.com LSB Industries Reaches Agreement Establishing a Pathway to 100% Ownership of El Dorado CCS Project OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB” or “the Company”), today announced that it has reached an agreement with Lapis Carbon Solutions (“Lapis”) that establishes a…
globenewswire.com LSBCF Investors Have Opportunity to Join LakeShore Biopharma Co., Ltd Fraud Investigation with the Schall Law Firm LOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of LakeShore…
businesswire.com LSB Industries, Inc. Reports Operating Results for the 2026 First Quarter OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the first quarter ended March 31, 2026. First Quarter 2026…
businesswire.com LSB Industries, Inc. Schedules 2026 First Quarter Results Release for Wednesday, April 29th and Conference Call for Thursday, April 30th OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the first quarter ended March 31, 2026 on April 29, 2026 after…
businesswire.com LSB Industries, Inc. Appoints Jonathan Ackerman as an Independent Member of the Board of Directors; Announces Retirement of Steve Packebush OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB” or “the Company”), (NYSE: LXU) today announced that it has appointed Jonathan Z. Ackerman as an independent member of the Board of…
prnewswire.com LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company BEIJING, March 25, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to…
seekingalpha.com LSB Industries: Strong 2025 And Massive NOLs Lead To Poison Pill Defense LSB Industries is upgraded to buy after strong FY25 results, robust NOL carryforwards, and an optimistic 2026 outlook. LXU reported FY25 revenues up 22.3% YoY and EPS of $0.22, beating estimates,…
businesswire.com LSB Industries, Inc. Reports Operating Results for the 2025 Fourth Quarter and Full Year and Provides Product Sales Volume Outlook for 2026 OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (NYSE: LXU) (“LSB,” “we,” “us,” “our,” or the “Company”) today announced results for the fourth quarter and full year ended December 31, 2025.…
businesswire.com LSB Industries, Inc. Schedules 2025 Fourth Quarter and Full Year Results Release for Wednesday, February 25th and Conference Call for Thursday, February 26th OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”) (NYSE: LXU), today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025 on…
prnewswire.com LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering,…
prnewswire.com LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders BEIJING, Jan. 20, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering,…
businesswire.com LSB Industries, Inc. to Participate in NYSE Industrials Virtual Conference OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”), (NYSE: LXU), today announced that its Executive Vice President and Chief Financial Officer, Cheryl Maguire will be participating in the…
prnewswire.com LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction BEIJING , Nov. 4, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering,…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why AES Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket Shares of The AES Corporation (NYSE:AES) rose sharply in pre-market trading following reports the company has received takeover interest.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com Why ReShape Lifesciences Shares Are Trading Higher By Over 82%; Here Are 20 Stocks Moving Premarket 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session